Physicians' Academy for Cardiovascular Education

Exploring the role of a novel CETP inhibitor in lipid management

10' education - Oct. 12, 2023 - Roxana Mehran, MD - New York, NY, USA

Video navigation menu

  • ROSE trial: obicetrapib on top of high-intensity statins (HIS) 02:28
  • ROSE2 trial: obicetrapib/ezetimibe on top of HIS 05:28
  • Current clinical trial programs with obicetrapib 09:12
  • Conclusion 12:41


Show transcript

Educational information

This lecture by Roxana Mehran was part of the EBAC-accredited symposium "Role of CETP inhibitors in cardiovascular risk reduction - Will lessons from the past lead to future success?" at the ESC Congress 2023.


Roxana Mehran is Professor of Medicine (Cardiology), Professor of Population Health Science and Policy, and Director of the Women’s Heart and Vascular Center at Mount Sinai Heart, New York, USA.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Menarini and NewAmsterdam Pharma.

View slides of this presentation Watch the other videos of this series

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: